OrbiMed’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,680,496
| Closed | -$106M | – | 125 |
|
|
2024
Q1 | $106M | Buy |
2,680,496
+145,251
| +6% | +$4.29M | 1.95% | 12 |
|
|
2023
Q4 | $48.3M | Sell |
2,535,245
-1,546,347
| -38% | -$21.5M | 0.97% | 38 |
|
|
2023
Q3 | $46.7M | Hold |
4,081,592
| – | – | 0.99% | 38 |
|
|
2023
Q2 | $42M | Hold |
4,081,592
| – | – | 0.76% | 47 |
|
|
2023
Q1 | $31.5M | Hold |
4,081,592
| – | – | 0.62% | 54 |
|
|
2022
Q4 | $30M | Hold |
4,081,592
| – | – | 0.57% | 58 |
|
|
2022
Q3 | $29.4K | Hold |
4,081,592
| – | – | 0.55% | 60 |
|
|
2022
Q2 | $34.7K | Hold |
4,081,592
| – | – | 0.63% | 49 |
|
|
2022
Q1 | $36.6M | Hold |
4,081,592
| – | – | 0.59% | 48 |
|
|
2021
Q4 | $56.5M | Hold |
4,081,592
| – | – | 0.73% | 45 |
|
|
2021
Q3 | $43.6M | Buy |
4,081,592
+1,010,637
| +33% | +$9.31M | 0.48% | 59 |
|
|
2021
Q2 | $27.6M | Hold |
3,070,955
| – | – | 0.28% | 86 |
|
|
2021
Q1 | $32.6M | Hold |
3,070,955
| – | – | 0.3% | 78 |
|
|
2020
Q4 | $38.7M | Sell |
3,070,955
-600,000
| -16% | -$5.89M | 0.34% | 71 |
|
|
2020
Q3 | $32.3M | Hold |
3,670,955
| – | – | 0.41% | 66 |
|
|
2020
Q2 | $35.6M | Hold |
3,670,955
| – | – | 0.5% | 58 |
|
|
2020
Q1 | $10.6M | Hold |
3,670,955
| – | – | 0.18% | 84 |
|
|
2019
Q4 | $14.1M | Hold |
3,670,955
| – | – | 0.2% | 73 |
|
|
2019
Q3 | $14.5M | Hold |
3,670,955
| – | – | 0.28% | 73 |
|
|
2019
Q2 | $15.5M | Hold |
3,670,955
| – | – | 0.24% | 79 |
|
|
2019
Q1 | $25.2M | Buy |
3,670,955
+372,439
| +11% | +$2.32M | 0.39% | 63 |
|
|
2018
Q4 | $12.1M | Hold |
3,298,516
| – | – | 0.22% | 81 |
|
|
2018
Q3 | $20.9M | Hold |
3,298,516
| – | – | 0.25% | 87 |
|
|
2018
Q2 | $25M | Hold |
3,298,516
| – | – | 0.3% | 75 |
|
|
2018
Q1 | $26.4M | Hold |
3,298,516
| – | – | 0.33% | 71 |
|
|
2017
Q4 | $36.9M | Hold |
3,298,516
| – | – | 0.47% | 62 |
|
|
2017
Q3 | $38.3M | Buy |
+3,298,516
| New | +$30.8M | 0.37% | 73 |
|
|
2016
Q4 | – | Sell |
-14,750
| Closed | -$480K | – | 142 |
|
|
2016
Q3 | $480K | Buy |
+14,750
| New | +$359K | 0.01% | 138 |
|
OrbiMed's ALPN Position: Q2 2024 in Review
OrbiMed sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 2,680,496 shares — an estimated $106M sold.
OrbiMed first reported a position in ALPN in Q3 2016 and held it in 28 quarters. The position peaked at $106M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- OrbiMed reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- OrbiMed sold 2,680,496 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $106M.
- OrbiMed first reported a position in Alpine Immune Sciences Inc in Q3 2016 and held it in 28 quarters.
- OrbiMed's Alpine Immune Sciences Inc position peaked at $106M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on OrbiMed's 13F filing for Q2 2024, filed 14 Aug 2024.